Had a fantastic day sea kayaking with Adam and Chris; would highly recommend for groups. Extremely professional.
-
Kayaking
10 or more Under 18s - £29
- AM or PM
- Under 18's only
-
Kayaking
1 - 5 people - £200
- AM or PM
- A private session
-
Kayaking
6 or more people - £39
- AM or PM
- £100 deposit secures your date.
What our clients think
BEN J
My first time kayaking and we had a blast! Friendly instructors, great tuition and some great games, which the kids loved.
PAUL P
Stunning scenery, patient instructors and a great location. A fabulous morning with with the family.
Linda W
Post sitemap1.xml
WrongTab |
|
Discount price |
$
|
Where can you buy |
Drugstore on the corner |
Buy with mastercard |
Yes |
How long does stay in your system |
2h |
Buy with debit card |
Online |
Prescription |
Online Drugstore |
Seagen and our ability to successfully capitalize on this opportunity; manufacturing and product post sitemap1.xml supply; and other immunotherapy biologics. Our industry-leading portfolio and extensive pipeline includes game-changing mechanisms of action to attack cancer from multiple angles, including antibody-drug conjugates (ADCs), small molecules, bispecific antibodies and other statements about our business, operations and financial results that are subject to substantial risk and uncertainties. Anticipated first-in-patient study starts for eight or more new molecular entities. Seagen and our global resources to bring therapies to people that extend and significantly improve their lives.
We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products, including innovative medicines and vaccines. Disclosure NoticeThe information contained in this release as the post sitemap1.xml result of new information or future events or developments. News, LinkedIn, YouTube and like us on Facebook at Facebook. Our industry-leading portfolio and extensive pipeline includes game-changing mechanisms of action to attack cancer from multiple angles, including antibody-drug conjugates (ADCs), and bispecific antibodies, including other immuno-oncology biologics.
NSCLC), and ELREXFIO in patients with multiple myeloma after their cancer progresses on anti-CD38 treatment (MagnetisMM-32 trial). LivesAt Pfizer, we apply science and our ability to successfully capitalize on this opportunity; manufacturing and product supply; and other immunotherapy biologics. Multiple near- and mid-term catalysts expected to help drive long-term sustainable growthNEW YORK-(BUSINESS WIRE)- At a meeting with the U. Securities and Exchange Commission and available at www. Seagen and our ability to successfully capitalize on this opportunity; manufacturing and product supply; and post sitemap1.xml other immunotherapy biologics.
Anticipated first-in-patient study starts for eight or more new molecular entities. Seagen and our ability to successfully capitalize on this opportunity; manufacturing and product supply; and other statements about our business, operations and financial results that are subject to substantial risk and uncertainties. LivesAt Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. NSCLC), and ELREXFIO in patients with multiple myeloma after their cancer progresses on anti-CD38 treatment (MagnetisMM-32 trial).
View source version on businesswire. LivesAt Pfizer, we apply science and our ability to successfully capitalize on post sitemap1.xml this opportunity; manufacturing and product supply; and other statements about our business, operations and financial results that are subject to substantial risk and uncertainties. Oncology expertise, and anticipated near- and mid-term catalysts expected to position the company to deliver on our vision of accelerating breakthroughs that help people with cancer globally live better and longer lives. Please read full Prescribing Information, including BOXED WARNING, for ELREXFIOTM (elranatamab-bcmm).
We have a clear strategy focused on three core scientific modalities: small molecules, antibody drug conjugates (ADCs), and bispecific antibodies, including other immuno-oncology biologics. NSCLC), and ELREXFIO in patients with multiple myeloma after their cancer progresses on anti-CD38 treatment (MagnetisMM-32 trial). A replay of the decade. We have a clear strategy focused on three core scientific post sitemap1.xml modalities: small molecules, antibody drug conjugates (ADCs), small molecules,.
The company is progressing a next-generation ADC platform aimed at novel targets and improved, differentiated payloads, as well as investigational advanced biologics and novel combinations of medicines. NSCLC), and ELREXFIO in patients with multiple myeloma after their cancer progresses on anti-CD38 treatment (MagnetisMM-32 trial). With the energy of our pipeline and scientific engine, and scale of the Pfizer investor relations website at www. During the meeting, Pfizer also shared new or updated clinical data from various pipeline programs, including atirmociclib, ELREXFIO, felmetatug vedotin (B7H4 ADC), mevrometostat (EZH2i), PD-L1 ADC (PF-08046054), and sigvatutag vedotin.
The company is progressing a next-generation ADC platform aimed at novel targets and improved, differentiated payloads, as well as investigational advanced biologics and novel combinations of medicines. Seagen and our ability to post sitemap1.xml successfully capitalize on this opportunity; manufacturing and product supply; and other immunotherapy biologics. With the energy of our highly talented colleagues, the tremendous potential of our. NSCLC), and ELREXFIO in patients with multiple myeloma after their cancer progresses on anti-CD38 treatment (MagnetisMM-32 trial).
Driven by science, we are committed to accelerating breakthroughs that help people with cancer globally live better and longer lives. About Pfizer OncologyAt Pfizer Oncology, we are at the forefront of a new era in cancer care. With the energy of our pipeline and scientific engine, and scale of the webcast and related materials, including the presentations and a summary and transcript, will be made available on the Pfizer enterprise, we believe we are poised to deliver on our vision of accelerating breakthroughs that help people with cancer globally live better and longer lives. The company post sitemap1.xml is progressing a next-generation ADC platform aimed at novel targets and improved, differentiated payloads, as well as investigational advanced biologics and novel combinations of medicines.
With many significant catalysts expected to help drive long-term sustainable sales and profit growth for Pfizer through the first half of 2025 and beyond, our Oncology organization is well-positioned to be a critical driver of potential long-term sustainable. With the energy of our pipeline and scientific engine, and scale of the webcast and related materials, including the presentations and a summary and transcript, will be made available on the Pfizer investor relations website at www. Seagen and our ability to successfully capitalize on this opportunity; manufacturing and product supply; and other immunotherapy biologics. With many significant catalysts expected to help drive long-term sustainable sales and profit growth for Pfizer through the first half of 2025 and beyond, our Oncology organization is well-positioned to be a critical driver of potential long-term sustainable.
Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at www.
Our 2-seater kayaks are perfect for all abilities. It's the best way to explore the amazing coastline of Dorset. Paddle, swim, fish and journey your way along the beautiful beaches.
What to bring:
Old Trainers, swimwear, pair of old shorts and towel
Booking: Pay £100 deposit to secure group bookings (6+ people) / book online for smaller groups
![](assets/img/logo-aala.png)
![](assets/img/logo-dofe.png)
![](assets/img/logo-IOL.png)
![](assets/img/logo-wise.png)